BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3304736)

  • 1. Immunological reconstitution after bone marrow transplant with Campath-1 treated bone marrow.
    Parreira A; Smith J; Hows JM; Smithers SA; Apperley J; Rombos Y; Goldman JM; Gordon-Smith EC; Catovsky D
    Clin Exp Immunol; 1987 Jan; 67(1):142-50. PubMed ID: 3304736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Reconstitution of peripheral blood lymphocytes in patients treated with bone marrow transplantation: comparison between allogeneic and autologous transplantation].
    Parra C; Roldán E; Rodríguez C; Pérez de Oteyza J; Oteho E; López J; Maldonado MS; García Laraña J; Muñoz A; Odriozola J; Brieva JA
    Med Clin (Barc); 1999 Jun; 113(1):1-5. PubMed ID: 10422068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The phenotype and reconstitution of immunoregulatory T cell subsets after T cell-depleted allogeneic and autologous bone marrow transplantation.
    Sugita K; Soiffer RJ; Murray C; Schlossman SF; Ritz J; Morimoto C
    Transplantation; 1994 May; 57(10):1465-73. PubMed ID: 7910987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reconstitution of lymphocyte subpopulations after paediatric bone marrow transplantation.
    de Vries E; van Tol MJ; van den Bergh RL; Waaijer JL; ten Dam MM; Hermans J; Vossen JM
    Bone Marrow Transplant; 2000 Feb; 25(3):267-75. PubMed ID: 10673698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphocyte subset reconstitution after HLA-identical placental blood transplantation (PBT) or PBT plus bone marrow transplantation (BMT) in three children with beta-thalassemia major.
    Vitucci A; Lucivero G; Locatelli F; Capocasale M; Tannoia N; Pietrapertosa A
    Bone Marrow Transplant; 2000 Oct; 26(7):743-7. PubMed ID: 11042655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic and functional reconstitution of peripheral blood lymphocytes following T cell-depleted bone marrow transplantation from partially mismatched related donors.
    Lamb LS; Gee AP; Henslee-Downey PJ; Geier SS; Hazlett L; Pati AR; Godder K; Abhyankar SA; Turner MW; Lee C; Harris WG; Parrish RS
    Bone Marrow Transplant; 1998 Mar; 21(5):461-71. PubMed ID: 9535038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective T cell depletion of donor allogeneic marrow with anti-CD6 monoclonal antibody: rationale and results.
    Soiffer RJ; Ritz J
    Bone Marrow Transplant; 1993; 12 Suppl 3():S7-10. PubMed ID: 8124262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial review of immunotherapeutic pharmacology in stem cell transplantation.
    Bierman PJ; Abe F; Buyukberber S; Ino K; Talmadge JE
    In Vivo; 2000; 14(1):221-36. PubMed ID: 10757081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune reconstitution after autologous hematopoietic stem cell transplantation in relation to underlying disease, type of high-dose therapy and infectious complications.
    Steingrimsdottir H; Gruber A; Björkholm M; Svensson A; Hansson M
    Haematologica; 2000 Aug; 85(8):832-8. PubMed ID: 10942930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal T-lymphocyte colonies (CFU-TL) following bone marrow transplantation.
    Mitsuyasu RT; Li SN; Champlin RE; Gale RP
    Exp Hematol; 1986 Dec; 14(11):1049-55. PubMed ID: 3536545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of cytomegalovirus infection on T lymphocytes after allogeneic bone marrow transplantation.
    Würsch AM; Gratama JW; Middeldorp JM; Nissen C; Gratwohl A; Speck B; Jansen J; D'Amaro J; The TH; De Gast GC
    Clin Exp Immunol; 1985 Nov; 62(2):278-87. PubMed ID: 3002684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of T cell activation antigen CD134 (OX40) has no predictive value for the occurrence or response to therapy of acute graft-versus-host disease in partial T cell-depleted bone marrow transplantation.
    Gadisseur AP; Gratama JW; Lamers C; van Esser JW; Bolhuis RL; Cornelissen JJ
    Bone Marrow Transplant; 1999 May; 23(10):1013-7. PubMed ID: 10373067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transition of T cell receptor gamma/delta expressing double negative (CD4-/CD8-) lymphocytes after allogeneic bone marrow transplantation.
    Yabe M; Yabe H; Hattori K; Hinohara T; Morimoto T; Kato S; Kusunoki A
    Bone Marrow Transplant; 1994 Nov; 14(5):741-6. PubMed ID: 7889006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro analysis of donor bone marrow following monoclonal antibody treatment for the prevention of acute graft versus host disease.
    Kohler PC; Erickson C; Finlay JL; Trigg ME; Edwards B; Hong R; Hank JA; Billing R; Bozdech M; Sondel PM
    Cancer Res; 1986 Oct; 46(10):5413-8. PubMed ID: 3530439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune reconstitution following allogeneic peripheral blood stem cell transplants.
    Shenoy S; Mohanakumar T; Todd G; Westhoff W; Dunnigan K; Adkins DR; Brown RA; DiPersio JF
    Bone Marrow Transplant; 1999 Feb; 23(4):335-46. PubMed ID: 10100577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regeneration of functional and activated NK and T sub-subset cells in the marrow and blood after autologous bone marrow transplantation: a prospective phenotypic study with 2/3-color FACS analysis.
    Bengtsson M; Tötterman TH; Smedmyr B; Festin R; Oberg G; Simonsson B
    Leukemia; 1989 Jan; 3(1):68-75. PubMed ID: 2535882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural killer cells in peripheral blood after autologous bone marrow transplantation: a combined phenotypic and functional study.
    Jorgensen H; Hokland P; Jensen T; Basse P; Hokland M
    Nat Immun; 1995; 14(3):164-72. PubMed ID: 8832900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of T-, B- and NK-cell reconstitution following conventional or nonmyeloablative conditioning and transplantation with bone marrow or peripheral blood stem cells from human leucocyte antigen identical sibling donors.
    Petersen SL; Ryder LP; Björk P; Madsen HO; Heilmann C; Jacobsen N; Sengeløv H; Vindeløv LL
    Bone Marrow Transplant; 2003 Jul; 32(1):65-72. PubMed ID: 12815480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The reappearance of 10 differentiation antigens on peripheral blood lymphocytes after allogeneic bone marrow transplantation.
    Leino L; Lilius EM; Nikoskelainen J; Pelliniemi TT; Rajamäki A
    Bone Marrow Transplant; 1991 Nov; 8(5):339-44. PubMed ID: 1768967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different immune reconstitution in multiple myeloma, chronic myeloid leukemia and acute myeloid leukemia patients after allogeneic transplantation of peripheral blood stem cells.
    Rondelli D; Re F; Bandini G; Raspadori D; Arpinati M; Senese B; Stanzani M; Bonifazi F; Falcioni S; Chirumbolo G; Tura S
    Bone Marrow Transplant; 2000 Dec; 26(12):1325-31. PubMed ID: 11223973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.